BlackRock Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$37K Sell
4,773
-553
-10% -$4.14K ﹤0.01% 3329
2016
Q3
$41K Buy
5,326
+1,642
+45% +$9.29K ﹤0.01% 3307
2016
Q2
$19K Hold
3,684
﹤0.01% 3457
2016
Q1
$20K Hold
3,684
﹤0.01% 3429
2015
Q4
$27K Sell
3,684
-3,207
-47% -$21.6K ﹤0.01% 3406
2015
Q3
$32K Buy
6,891
+208
+3% +$1.98K ﹤0.01% 3409
2015
Q2
$74K Buy
+6,683
New +$65.8K ﹤0.01% 3254

Other funds holding VCYT

BlackRock Advisors's VCYT Position: Q4 2016 in Review

BlackRock Advisors reduced its Veracyte (VCYT) stake by 10% in Q4 2016, selling an estimated $4.14K and leaving 4,773 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #3329.

BlackRock Advisors first reported a position in VCYT in Q2 2015 and has held it in 7 quarters since. The position peaked at $74K in Q2 2015. 74 funds tracked by Wall St. Rank hold VCYT as of Q4 2016.

  • BlackRock Advisors held 4,773 shares of Veracyte worth $37K as of Q4 2016.
  • BlackRock Advisors sold 553 Veracyte shares in Q4 2016, an estimated $4.14K.
  • Veracyte made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3329 holding.
  • BlackRock Advisors first reported a position in Veracyte in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Advisors's Veracyte position peaked at $74K in Q2 2015.
  • 74 funds tracked by Wall St. Rank held Veracyte as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.